We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+6.85%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$36.4B
AUM Growth
+$2.59B
Cap. Flow
+$610M
Cap. Flow %
1.67%
Top 10 Hldgs %
16.21%
Holding
1,499
New
44
Increased
654
Reduced
471
Closed
52

Sector Composition

Rank Sector Weight
1 Financials 17.33%
2 Technology 16.38%
3 Healthcare 12.64%
4 Industrials 10.07%
5 Communication Services 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYGR icon
1401
Voyager Therapeutics
VYGR
$197M
$166K ﹤0.01%
10,000
ARDX icon
1402
Ardelyx
ARDX
$1.03B
$165K ﹤0.01%
25,000
TFSL icon
1403
TFS Financial
TFSL
$4.89B
$162K ﹤0.01%
10,834
+367
+4% +$5.65K
CMRX
1404
DELISTED
Chimerix, Inc.
CMRX
$157K ﹤0.01%
34,000
PETX
1405
DELISTED
Aratana Therapeutics, Inc.
PETX
$153K ﹤0.01%
29,000
MCRB icon
1406
Seres Therapeutics
MCRB
$47.4M
$152K ﹤0.01%
750
CORI
1407
DELISTED
Corium International, Inc.
CORI
$144K ﹤0.01%
15,000
NEOS
1408
DELISTED
Neos Therapeutics, Inc
NEOS
$143K ﹤0.01%
14,000
PGEN icon
1409
Precigen
PGEN
$2.45B
$142K ﹤0.01%
12,293
KIN
1410
DELISTED
Kindred Biosciences, Inc.
KIN
$142K ﹤0.01%
15,000
PDSB icon
1411
PDS Biotechnology
PDSB
$13.5M
$141K ﹤0.01%
750
LUMO
1412
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$138K ﹤0.01%
1,889
ATHX
1413
DELISTED
Athersys, Inc. Common Stock
ATHX
$136K ﹤0.01%
3,000
LCTX icon
1414
Lineage Cell Therapeutics
LCTX
$278M
$123K ﹤0.01%
65,151
SBBP
1415
DELISTED
Strongbridge Biopharma plc.
SBBP
$116K ﹤0.01%
16,000
CCXI
1416
DELISTED
ChemoCentryx, Inc.
CCXI
$113K ﹤0.01%
19,000
TLGT
1417
DELISTED
Teligent, Inc
TLGT
$113K ﹤0.01%
3,100
VCYT icon
1418
Veracyte
VCYT
$3.59B
$111K ﹤0.01%
17,000
MACK
1419
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$111K ﹤0.01%
13,726
NERV icon
1420
Minerva Neurosciences
NERV
$187M
$109K ﹤0.01%
2,250
CLSD
1421
DELISTED
Clearside Biomedical
CLSD
$105K ﹤0.01%
1,000
SIOX
1422
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$105K ﹤0.01%
2,500
OTIC
1423
DELISTED
Otonomy, Inc.
OTIC
$105K ﹤0.01%
19,000
VRDN icon
1424
Viridian Therapeutics
VRDN
$2.59B
$104K ﹤0.01%
667
CASC
1425
DELISTED
Cascadian Therapeutics, Inc.
CASC
$104K ﹤0.01%
28,000

Similar funds

State of Wisconsin Investment Board's Q4 2017 Portfolio in Review

As of Q4 2017, State of Wisconsin Investment Board held 1,499 positions worth $36.4B, up 7.6% from $33.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

State of Wisconsin Investment Board's Q4 2017 filing shows 44 new, 654 increased, 471 reduced and 52 closed positions. Its largest new stake was Liberty Global Class C: 1,115,354 shares worth $37.7M. The largest sale was Alphabet (Google) Class A, an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • State of Wisconsin Investment Board's largest Q4 2017 buy was Liberty Global Class C: 1,115,354 shares worth $37.7M.
  • State of Wisconsin Investment Board added most to Discovery, Inc. Series C Common Stock in Q4 2017, an estimated $125M increase.
  • State of Wisconsin Investment Board's biggest Q4 2017 reduction was Alphabet (Google) Class A, cutting an estimated $62.1M.
  • State of Wisconsin Investment Board fully exited CR Bard Inc. in Q4 2017, selling an estimated $47.7M.
  • State of Wisconsin Investment Board's ten largest holdings make up 16% of its $36.4B portfolio in Q4 2017.
  • State of Wisconsin Investment Board opened 44 new positions and closed 52 in Q4 2017.
  • State of Wisconsin Investment Board's portfolio value rose 7.6% quarter-over-quarter to $36.4B.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2017, filed 8 Feb 2018.